INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-04-15 ms8000001219428297 来自辽宁省

偏重的研究方向：发育
经验分享：投稿时间线：
2025-2-19 在线提交
2025-2-19 开始审稿
2025-3-12 第一轮Major revisions（共4个审稿人）
2025-4-2 提交修回稿
2025-4-9 第二轮Major revisions
2025-4-15 再次提交修回稿正在等待结果中，希望好运

11 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-04-28 146dabedm72暂无昵称来自北京

请问这个杂志版面费多少啊？

6 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-05-06 研骨小虫冲来自浙江省

偏重的研究方向：骨质疏松
经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态

5 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-04-26 ms7000000921712169 来自广东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：肿瘤生信分析
经验分享：现在pending的时间是变长了吗

7 0

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-04-07 lssmd 来自黑龙江省

偏重的研究方向：转化
经验分享：4月上旬投稿，记录

13 0

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-03-17 ms5000002977722150 来自上海

记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利
3.13开始投稿
目前pending review没有变化

15 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2024-05-22 ms4000001066891631 来自江西省

偏重的研究方向：肝脏疾病;肿瘤
经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。

125 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2025-01-12 ms5000002977722138 来自上海

分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。
13 December 24 提交
16 December 24 开始审稿
25 December 24 审稿人提出重大修改意见
4 Jan 25 返回修订稿
7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件
10 Jan 25 学术编辑提出小幅度修改意见

25 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2024-12-21 malonglee 来自上海

挺好的杂志，审稿很认真，也没有预警，值得一投

30 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2260532, encodeId=750b226053290, content=偏重的研究方向：发育 经验分享：投稿时间线： 2025-2-19 在线提交 2025-2-19 开始审稿 2025-3-12 第一轮Major revisions（共4个审稿人） 2025-4-2 提交修回稿 2025-4-9 第二轮Major revisions 2025-4-15 再次提交修回稿正在等待结果中，希望好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=23318277764, createdName=ms8000001219428297, createdTime=Tue Apr 15 11:14:46 CST 2025, time=2025-04-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2262596, encodeId=910422625966c, content=请问这个杂志版面费多少啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=6, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fb925171815, createdName=146dabedm72暂无昵称, createdTime=Mon Apr 28 11:28:44 CST 2025, time=2025-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2263672, encodeId=ef9b22636e23d, content=偏重的研究方向：骨质疏松 经验分享：记录一下：5.1 pending review 目前5.6仍旧原先状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=5, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKZk2vJMmQIUtK3w9m0u6dmMl9A4TS6V7FRicrV1DEhYFZFBeYTJIn4KwqaGlvic6iap4aAx8grozrbA/132, createdBy=bd455315940, createdName=研骨小虫冲, createdTime=Tue May 06 08:59:52 CST 2025, time=2025-05-06, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2262340, encodeId=1d80226234078, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：肿瘤生信分析 经验分享：现在pending的时间是变长了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0578477592, createdName=ms7000000921712169, createdTime=Sat Apr 26 10:41:59 CST 2025, time=2025-04-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2259467, encodeId=a53c225946e16, content=偏重的研究方向：转化 经验分享：4月上旬投稿，记录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/392EF952E79DBD31432C86E1D99AF01C/100, createdBy=03d22194782, createdName=lssmd, createdTime=Mon Apr 07 17:21:28 CST 2025, time=2025-04-07, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2256518, encodeId=a824225651810, content=记录一下我的投稿过程，据说这个期刊拒稿很麻溜，不拖拉，挺好的，希望我的一切顺利 3.13开始投稿 目前pending review没有变化, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722150, createdTime=Mon Mar 17 23:28:45 CST 2025, time=2025-03-17, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2206064, encodeId=0e7c2206064f1, content=偏重的研究方向：肝脏疾病;肿瘤 经验分享：现在pending的时间是变长了吗，看到23年的基本都是隔天送审，我已经pending4天了慌张。。。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74479171808, createdName=ms4000001066891631, createdTime=Wed May 22 18:36:10 CST 2024, time=2024-05-22, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2247725, encodeId=f336224e72528, content=分享一下我从投稿到审稿、再到根据审稿意见进行修订的整个过程，比较关键的时间节点，分享给大家供大家参考。 13 December 24 提交 16 December 24 开始审稿 25 December 24 审稿人提出重大修改意见 4 Jan 25 返回修订稿 7 Jan 25 审稿人小修审稿人响应速度很及时，当天提交了修订后的稿件 10 Jan 25 学术编辑提出小幅度修改意见, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms5000002977722138, createdTime=Sun Jan 12 19:23:30 CST 2025, time=2025-01-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2244137, encodeId=26d3224413e92, content=挺好的杂志，审稿很认真，也没有预警，值得一投 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fa371702984, createdName=malonglee, createdTime=Sat Dec 21 20:15:04 CST 2024, time=2024-12-21, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2243584, encodeId=709f224358491, content=恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1f0e2441357, createdName=123d6734m83(暂无昵称), createdTime=Thu Dec 19 21:24:44 CST 2024, time=2024-12-19, status=1, ipAttribution=江苏省)]

2024-12-19 123d6734m83(暂无昵称) 来自江苏省

恶心巴拉的杂志，遇到一个恶心巴拉的reviewer，不认可你的实验，完了editor给了大修，反复大修了2次，editor又给了小修，结果小修回去editor又给拒了，真恶心人。纯纯浪费时间。

26 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务